2017
A patient with oxaliplatin immune-induced syndrome (OIIS) who also developed leucovorin and palonosetron-associated thrombocytopenia
Curtis SA, Curtis BR, Lee AI, Hendrickson JE, Lacy J, Podoltsev NA. A patient with oxaliplatin immune-induced syndrome (OIIS) who also developed leucovorin and palonosetron-associated thrombocytopenia. Hematology 2017, 23: 429-432. PMID: 29281948, DOI: 10.1080/10245332.2017.1419600.Peer-Reviewed Original ResearchConceptsDrug-induced immune thrombocytopeniaAutoimmune hemolytic anemiaPlatelet-reactive antibodiesImmune thrombocytopeniaThrombotic microangiopathyAdministration of oxaliplatinCycles of FOLFOXOxaliplatin-induced thrombocytopeniaYear old manAnti-RBC IgGEvans syndromeAntibody testingFirst admissionIgM antibodiesSignificant thrombocytopeniaIgG antibodiesHemolytic anemiaThrombocytopeniaLeucovorinPlatelet IgGOlder menOxaliplatinSyndromeBlood centersPatients
2013
Chapter 64 Transfusion-Related Acute Lung Injury
Hendrickson J, Hillyer C. Chapter 64 Transfusion-Related Acute Lung Injury. 2013, 417-420. DOI: 10.1016/b978-0-12-397164-7.00064-1.Peer-Reviewed Original ResearchTransfusion-related acute lung injuryTRALI mitigation strategiesAcute lung injuryLung injuryConsensus panel criteriaTransfusion-related mortalityNoncardiogenic pulmonary edemaPulmonary edemaClinical syndromeAcute hypoxiaBlood productsPanel criteriaTransfusionInjuryFDALaboratory testsHypotensionEdemaFeverSyndromeMortalityIncidenceDiagnosisHypoxia